Chiranjeev Dash1, Pamela D Randolph-Jackson2, Claudine Isaacs3, Mary Mills3, Kepher Makambi4, Vivian V Watkins3, Lucile L Adams-Campbell3. 1. Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States. Electronic address: cd422@georgetown.edu. 2. Department of Radiation Oncology, Medstar Washington Hospital Center, Washington, D.C., United States. 3. Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States. 4. Georgetown Lombardi Comprehensive Cancer Center, Biostatistics & Bioinformatics Shared Resource, Washington, D.C., United States.
Abstract
BACKGROUND:Cancer related fatigue (CRF) is a common and debilitating side-effect of radiotherapy in breast cancer patients. Physical activity interventions can attenuate CRF but evidence in African-American women with breast cancer is lacking. METHODS/ DESIGN: The "Pedlar" Study is a prospective, 8-week structured moderate-intensity exercise intervention, delivered concurrently with radiotherapy, to reduce CRF and improve health-related quality of life among African American breast cancer patients. Forty African American women with breast cancer scheduled to receive radiation therapy at MedStar Washington Hospital Center will be randomized to one of the two trial arms: 1) a facility-based aerobic exercise utilizing a portable stationary pedal exerciser; and 2) a control group. Intervention arm participants will exercise at the hospital either before or after their radiation treatment. Assessments will be conducted at baseline, 4, and 8 weeks. The outcome variables are CRF, biomarkers of inflammation, and health-related quality of life. DISCUSSION: The Pedlar Study will provide preliminary evidence on whether a short-term moderate-intensity exercise intervention might be effective in reducing CRF in African American women undergoing radiotherapy for breast cancer, and whether this effect is mediated by inflammation.
RCT Entities:
BACKGROUND:Cancer related fatigue (CRF) is a common and debilitating side-effect of radiotherapy in breast cancerpatients. Physical activity interventions can attenuate CRF but evidence in African-American women with breast cancer is lacking. METHODS/ DESIGN: The "Pedlar" Study is a prospective, 8-week structured moderate-intensity exercise intervention, delivered concurrently with radiotherapy, to reduce CRF and improve health-related quality of life among African American breast cancerpatients. Forty African American women with breast cancer scheduled to receive radiation therapy at MedStar Washington Hospital Center will be randomized to one of the two trial arms: 1) a facility-based aerobic exercise utilizing a portable stationary pedal exerciser; and 2) a control group. Intervention arm participants will exercise at the hospital either before or after their radiation treatment. Assessments will be conducted at baseline, 4, and 8 weeks. The outcome variables are CRF, biomarkers of inflammation, and health-related quality of life. DISCUSSION: The Pedlar Study will provide preliminary evidence on whether a short-term moderate-intensity exercise intervention might be effective in reducing CRF in African American women undergoing radiotherapy for breast cancer, and whether this effect is mediated by inflammation.
Authors: Tereza Raquel de M Alcântara-Silva; Ruffo Freitas-Junior; Nilceana M A Freitas; Graziela D P Machado Journal: J Clin Nurs Date: 2013-05-08 Impact factor: 3.036
Authors: Friederike Scharhag-Rosenberger; Rea Kuehl; Oliver Klassen; Kai Schommer; Martina E Schmidt; Cornelia M Ulrich; Joachim Wiskemann; Karen Steindorf Journal: J Cancer Surviv Date: 2015-02-26 Impact factor: 4.442
Authors: B Fisher; J Dignam; N Wolmark; E Mamounas; J Costantino; W Poller; E R Fisher; D L Wickerham; M Deutsch; R Margolese; N Dimitrov; M Kavanah Journal: J Clin Oncol Date: 1998-02 Impact factor: 44.544
Authors: Victoria Mock; Constantine Frangakis; Nancy E Davidson; Mary E Ropka; Mary Pickett; Barbara Poniatowski; Kerry J Stewart; Lane Cameron; Kristin Zawacki; Laura J Podewils; Gary Cohen; Ruth McCorkle Journal: Psychooncology Date: 2005-06 Impact factor: 3.894
Authors: Hans Christiansen; Bernhard Saile; Robert M Hermann; Margret Rave-Fränk; Andrea Hille; Heinz Schmidberger; Clemens F Hess; Giuliano Ramadori Journal: J Cancer Res Clin Oncol Date: 2006-11-25 Impact factor: 4.553